Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermatop Basecreme
- Development stage
- Phase 2
- Lead developer
- Fidia Farmaceutici
- Administration
- Topical
01
Overview
Dermatop Basecreme is the vehicle (base) cream formulation for the Dermatop product line, which typically contains the active pharmaceutical ingredient prednicarbate, a nonhalogenated corticosteroid. As a standalone product, Dermatop Basecreme does not contain an active pharmaceutical ingredient and is primarily used as an emollient or as a placebo/comparator in clinical research. In a Phase 2 imaging study conducted by the Technical University Dresden, it was utilized as a comparator to assess epidermal and dermal thickness changes in patients with atopic dermatitis using optical coherence tomography (OCT) and 20-MHz ultrasound. It is designed to provide skin hydration and barrier support while being chemically compatible with prednicarbate.
- Brand names
- Dermatop Basecreme
- Other names
- Dermatop vehicle cream
Beyond the preview
Go deeper on Dermatop Basecreme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermatop Basecreme.